The classical drug discovery paradigm begins with a known molecular target: a protein whose modulation is expected to reverse ...
Everything we can see and touch, and quite a lot that we can’t as well, is made of tiny particles called atoms. Some substances, like particles of this iron, contain only one kind of atom. Iron is an ...
Chemical reactions are the backbone to nearly all biological processes, including those used to make new medicines. However, ...
Researchers have developed a facile water-based synthetic route for constructing fused azole–pyrimidine energetic materials, producing compounds with high thermal stability, strong detonation ...
Julian Fairey, an associate professor of civil engineering at the University of Arkansas, was the first co-author on the paper published in Science. Fairey noted that researchers have known about the ...
Morning Overview on MSN
A new vitamin K-based compound just helped the brain regrow lost neurons in the lab — engineered straight at Alzheimer’s and Parkinson’s
Most drugs aimed at Alzheimer’s and Parkinson’s disease try to slow the damage. A small team at Japan’s Shibaura Institute of Technology is asking a different question: what if you could coax the ...
Discover how agentic AI can improve compound and sample management for laboratories, prepare documentation, and improve data ...
Scientists at Kyoto University's Institute for Cell-Material Sciences have discovered a novel cluster compound that could prove useful as a catalyst. Compounds, called polyoxometalates, contain a ...
Researchers at Shibaura Institute of Technology synthesized hybrid vitamin K molecules that produced neurons at three times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results